BRIM Biotechnology brings together experts across science, engineering, and technology disciplines to deliver a more efficient, less costly, drug development process. Our talented team has forged decades worth of strong global connections and experience. We operate based on a virtual team model, integrating our expert R&D operation team in Taiwan with our skilled overseas scientific team. We have years of experience working in technological and pharmaceutical development, regulatory affairs, and marketing and IP, with expertise across the field of innovative drug development, including pre-clinical toxicology, clinical pharmacology, and management. We harness the power of our team’s expertise in translational science to deliver a difference for patients.
Team
Translational Science Expertise
BRIM R&D Operational Team
BRIM R&D
Operational Team
BRIM R&D
Operational Team
Pre-clinical & Toxicology
Dr. Frank Lee
Chief Scientific Officer
Dr. Frank Lee
Chief Scientific Officer
Vito Sasseville, D.V.M., Ph.D., Diplomate A.C.V.P.
Senior Consultant
Vito Sasseville, D.V.M., Ph.D., Diplomate A.C.V.P.
Senior Consultant
Vito Sasseville supported the Drug Safety groups at Bristol-Myers Squibb, Millennium Pharmaceuticals (Takeda), and the Novartis Institutes of Biomedical. Vito is recognized for his work in the safety assessment of ocular and is currently the owner of Coastal Pharmaceutical Consulting.
Cheng-Wen Lin
Chief Technology Officer
Cheng-Wen Lin
Chief Technology Officer
Clinical Pharmacology & Clinical Management
Wen Chyi Shyu, PhD
CEO
Wen Chyi Shyu, PhD
CEO
Vice President of Global Drug Metabolism and Pharmacokinetics at Takeda
30+ years of experience in drug metabolism and pharmacokinetics
Haishan Jang, PhD, MBA
Vice Chairman, CGS (Chief Global Strategist)
Haishan Jang, PhD, MBA
Vice Chairman, CGS (Chief Global Strategist)
Szu-Yun Leu, Ph.D.
Senior Consultant
Szu-Yun Leu, Ph.D.
Senior Consultant
Over 25 years’ experience in statistical consultation, grant preparation, study design and planning, database design and management, statistical analysis, and manuscript writing in various medical fields, including cancer research, exercise physiology, obesity, pulmonary disease, genomics, gas biomarkers, ophthalmology, and AIDS research.
CMC & Pharmaceutical Development
Dr. Wayne Liaw
Senior Consultant
Dr. Wayne Liaw
Senior Consultant
Previously held Senior Director positions at Otonomy and Optimer
Former director at Hollis-Eden pharma
Judy Yuan, Ph.D.
Senior Consultant
Judy Yuan, Ph.D.
Senior Consultant
Former Senior Director of Regulatory and CMC development at TaiGen Biotechnology, Taipei, Taiwan
Previously held Analytical R&D Senior Group Leader position at Abbot Laboratories (Now Abbie)
Mark Tucker, Ph.D.
Senior Consultant
Mark Tucker, Ph.D.
Senior Consultant
The President of Mark Tucker, LLC.
Expert in worldwide GMP Compliance with strong science background in biotechnology.
Regulatory Affairs
Dr. Li-Chun C. Wang"
Senior Consultant
Dr. Li-Chun C. Wang
Senior Consultant
President, LCWANG Regulatory Consulting, LLC
Previously held Vice President of Regulatory CMC at Solid Biosciences
40+ years of experience in drug development
Marketing and IP
Dr. Chyau Liang
Senior Consultant
Dr. Chyau Liang
Senior Consultant
Previously Partner at Osha Liang LLP
Former Professor at the University of Texas-Houston School of Medicine
SABs & KOLs
Dr. Pan-Chyr Yang
Scientific Board Member
Dr. Pan-Chyr Yang
Scientific Board Member
Academician at Academia Sinica and Professor at National Taiwan University
Previously President of National Taiwan University
Editor-in-Chief of MicroRNA and Lung Cancer: Targets and Therapy
Dr. Robert Ruffolo
Scientific Board Member
Dr. Robert Ruffolo
Scientific Board Member
Previously President of R&D and Corporate Senior Vice President of Wyeth Pharmaceuticals
Senior Vice President and Director of Research at SmithKline Beecham Pharmaceuticals
Chairman of the Cardiovascular Research Committee at Eli Lilly & Company
Dr. Eliot Lazar
Key Opinion Leader
Dr. Eliot Lazar
Key Opinion Leader
CEO at elCON Medical Consulting
Previously held Assistant Professor positions at the State University of NY and the University of Rochester
Victor L. Perez, Ph.D.
Scientific Board Member
Victor L. Perez, Ph.D.
Scientific Board Member
The Professor of Ophthalmology, University of Miami Miller School of Medicine.
Experienced and passionate Clinician-Scientist with a strong history of basic, translational and clinical research working with academic institutions in the field of cornea, ocular surface disease and uveitis.
